BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 35784909)

  • 1. An overview of SARS-COV-2-related hepatic injury.
    Tarik Aslan A; Yasemin Balaban H
    Hepatol Forum; 2021 Sep; 2(3):122-127. PubMed ID: 35784909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastrointestinal and Hepatic Manifestations of COVID-19: Evolving Recognition and Need for Increased Understanding in Vulnerable Populations.
    Garland V; Kumar AB; Borum ML
    J Natl Med Assoc; 2021 Apr; 113(2):142-146. PubMed ID: 32807512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic complications of COVID-19 and its treatment.
    Tian D; Ye Q
    J Med Virol; 2020 Oct; 92(10):1818-1824. PubMed ID: 32437004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 and liver injury: An ongoing challenge.
    Papagiouvanni I; Kotoulas SC; Pataka A; Spyratos DG; Porpodis K; Boutou AK; Papagiouvannis G; Grigoriou I; Vettas C; Goulis I
    World J Gastroenterol; 2023 Jan; 29(2):257-271. PubMed ID: 36687117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19-associated liver injury: Clinical characteristics, pathophysiological mechanisms and treatment management.
    Li P; Liu Y; Cheng Z; Yu X; Li Y
    Biomed Pharmacother; 2022 Oct; 154():113568. PubMed ID: 36029543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver Disease and Coronavirus Disease 2019: From Pathogenesis to Clinical Care.
    Saviano A; Wrensch F; Ghany MG; Baumert TF
    Hepatology; 2021 Aug; 74(2):1088-1100. PubMed ID: 33332624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 induced hepatic injuries and liver complications.
    Saeed U; Piracha ZZ; Uppal SR; Waheed Y; Uppal R
    Front Cell Infect Microbiol; 2022; 12():726263. PubMed ID: 36189356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of SARS-CoV-2 Invasion into the Liver and Hepatic Injury in Patients with COVID-19.
    Zhang X; Yu Y; Zhang C; Wang H; Zhao L; Wang H; Su Y; Yang M
    Mediterr J Hematol Infect Dis; 2022; 14(1):e2022003. PubMed ID: 35070210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired coagulation, liver dysfunction and COVID-19: Discovering an intriguing relationship.
    D'Ardes D; Boccatonda A; Cocco G; Fabiani S; Rossi I; Bucci M; Guagnano MT; Schiavone C; Cipollone F
    World J Gastroenterol; 2022 Mar; 28(11):1102-1112. PubMed ID: 35431501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19.
    Wang Y; Liu S; Liu H; Li W; Lin F; Jiang L; Li X; Xu P; Zhang L; Zhao L; Cao Y; Kang J; Yang J; Li L; Liu X; Li Y; Nie R; Mu J; Lu F; Zhao S; Lu J; Zhao J
    J Hepatol; 2020 Oct; 73(4):807-816. PubMed ID: 32437830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanisms underlying SARS-CoV-2 hepatotropism and liver damage.
    Quarleri J; Delpino MV
    World J Hepatol; 2024 Jan; 16(1):1-11. PubMed ID: 38313242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal Liver Biochemistry Tests and Acute Liver Injury in COVID-19 Patients: Current Evidence and Potential Pathogenesis.
    McGrowder DA; Miller F; Anderson Cross M; Anderson-Jackson L; Bryan S; Dilworth L
    Diseases; 2021 Jul; 9(3):. PubMed ID: 34287285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver Injury and Dysfunction Associated with COVID-19: a Review Article.
    Yahia AIO
    Clin Lab; 2022 Jan; 68(1):. PubMed ID: 35023684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 and the liver: What do we know so far?
    Nasa P; Alexander G
    World J Hepatol; 2021 May; 13(5):522-532. PubMed ID: 34131467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 induced liver injury from a new perspective: Mitochondria.
    Akbari H; Taghizadeh-Hesary F
    Mitochondrion; 2023 May; 70():103-110. PubMed ID: 37054906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 and Indirect Liver Injury: A Narrative Synthesis of the Evidence.
    Idalsoaga F; Ayares G; Arab JP; Díaz LA
    J Clin Transl Hepatol; 2021 Oct; 9(5):760-768. PubMed ID: 34722191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Host Response to SARS-CoV2 and Emerging Variants in Pre-Existing Liver and Gastrointestinal Diseases.
    Nayak B; Lal G; Kumar S; Das CJ; Saraya A; Shalimar
    Front Cell Infect Microbiol; 2021; 11():753249. PubMed ID: 34760721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 and comorbidities of hepatic diseases in a global perspective.
    Ahmad A; Ishtiaq SM; Khan JA; Aslam R; Ali S; Arshad MI
    World J Gastroenterol; 2021 Apr; 27(13):1296-1310. PubMed ID: 33833483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human and novel coronavirus infections in children: a review.
    Rajapakse N; Dixit D
    Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Impact of COVID-19 on Liver Injury.
    Dawood DRM; Salum GM; El-Meguid MA
    Am J Med Sci; 2022 Feb; 363(2):94-103. PubMed ID: 34752738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.